rs5030672

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_000211.5(ITGB2):​c.1756C>T​(p.Arg586Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00845 in 1,612,570 control chromosomes in the GnomAD database, including 128 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R586Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0079 ( 23 hom., cov: 33)
Exomes 𝑓: 0.0085 ( 105 hom. )

Consequence

ITGB2
NM_000211.5 missense

Scores

7
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.735

Publications

20 publications found
Variant links:
Genes affected
ITGB2 (HGNC:6155): (integrin subunit beta 2) This gene encodes an integrin beta chain, which combines with multiple different alpha chains to form different integrin heterodimers. Integrins are integral cell-surface proteins that participate in cell adhesion as well as cell-surface mediated signalling. The encoded protein plays an important role in immune response and defects in this gene cause leukocyte adhesion deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
ITGB2 Gene-Disease associations (from GenCC):
  • leukocyte adhesion deficiency 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_000211.5
BP4
Computational evidence support a benign effect (MetaRNN=0.055984765).
BP6
Variant 21-44889397-G-A is Benign according to our data. Variant chr21-44889397-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 9463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00791 (1204/152250) while in subpopulation NFE AF = 0.00676 (460/68000). AF 95% confidence interval is 0.00625. There are 23 homozygotes in GnomAd4. There are 772 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGB2NM_000211.5 linkc.1756C>T p.Arg586Trp missense_variant Exon 13 of 16 ENST00000652462.1 NP_000202.3 P05107A0A494C0X7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGB2ENST00000652462.1 linkc.1756C>T p.Arg586Trp missense_variant Exon 13 of 16 NM_000211.5 ENSP00000498780.1 A0A494C0X7

Frequencies

GnomAD3 genomes
AF:
0.00793
AC:
1206
AN:
152134
Hom.:
23
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00140
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00249
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.0596
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00678
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00859
AC:
2124
AN:
247144
AF XY:
0.00879
show subpopulations
Gnomad AFR exome
AF:
0.00139
Gnomad AMR exome
AF:
0.00143
Gnomad ASJ exome
AF:
0.00220
Gnomad EAS exome
AF:
0.0000546
Gnomad FIN exome
AF:
0.0534
Gnomad NFE exome
AF:
0.00762
Gnomad OTH exome
AF:
0.00780
GnomAD4 exome
AF:
0.00851
AC:
12428
AN:
1460320
Hom.:
105
Cov.:
33
AF XY:
0.00829
AC XY:
6024
AN XY:
726508
show subpopulations
African (AFR)
AF:
0.00128
AC:
43
AN:
33470
American (AMR)
AF:
0.00175
AC:
78
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.00203
AC:
53
AN:
26108
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39692
South Asian (SAS)
AF:
0.000870
AC:
75
AN:
86182
European-Finnish (FIN)
AF:
0.0489
AC:
2559
AN:
52354
Middle Eastern (MID)
AF:
0.00329
AC:
19
AN:
5768
European-Non Finnish (NFE)
AF:
0.00827
AC:
9191
AN:
1111732
Other (OTH)
AF:
0.00676
AC:
408
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
756
1512
2268
3024
3780
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00791
AC:
1204
AN:
152250
Hom.:
23
Cov.:
33
AF XY:
0.0104
AC XY:
772
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.00140
AC:
58
AN:
41550
American (AMR)
AF:
0.00248
AC:
38
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
0.0596
AC:
632
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00676
AC:
460
AN:
68000
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
63
126
188
251
314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00569
Hom.:
10
Bravo
AF:
0.00390
TwinsUK
AF:
0.00836
AC:
31
ALSPAC
AF:
0.00752
AC:
29
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00616
AC:
53
ExAC
AF:
0.00755
AC:
915
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22134107, 22995991, 20981092, 1346613, 28600779) -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ITGB2: BS2 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Leukocyte adhesion deficiency 1 Benign:3
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not specified Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

ITGB2-related disorder Benign:1
Mar 13, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
-0.020
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.10
.;.;T;.;.;.
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.26
.;.;T;.;.;T
MetaRNN
Benign
0.056
T;T;T;T;T;T
MetaSVM
Uncertain
-0.059
T
PhyloP100
-0.73
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-3.5
D;D;D;D;D;D
REVEL
Uncertain
0.49
Sift
Uncertain
0.0040
D;D;D;D;D;D
Sift4G
Uncertain
0.0080
D;D;D;D;D;D
Vest4
0.72
MVP
0.82
MPC
0.34
ClinPred
0.061
T
GERP RS
-9.8
gMVP
0.48
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030672; hg19: chr21-46309312; COSMIC: COSV56609809; COSMIC: COSV56609809; API